↓ Skip to main content
What is this page? Embed badge

Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
12 Mendeley
Summary News Dimensions citations
So far, Altmetric has seen 1 news story.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.